Business Description
Biodexa Pharmaceuticals Plc
ISIN : GB00BNGF1L75
Description
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.23 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -20.97 | |||||
| Beneish M-Score | 98.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.1 | |||||
| 3-Year EBITDA Growth Rate | 49.7 | |||||
| 3-Year FCF Growth Rate | 33.4 | |||||
| 3-Year Book Growth Rate | -26 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 75.35 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | -72.72 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -95.13 | |||||
| 12-1 Month Momentum % | -97.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.16 | |||||
| Quick Ratio | 2.16 | |||||
| Cash Ratio | 1.45 | |||||
| Days Sales Outstanding | 6211.6 | |||||
| Days Payable | 114.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.8 | |||||
| Shareholder Yield % | -234.65 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -4725.3 | |||||
| Operating Margin % | -9630.12 | |||||
| Net Margin % | -8215.66 | |||||
| FCF Margin % | -10841.67 | |||||
| ROE % | -109.37 | |||||
| ROA % | -63 | |||||
| ROIC % | -133.81 | |||||
| 3-Year ROIIC % | 45.85 | |||||
| ROC (Joel Greenblatt) % | -1234.24 | |||||
| ROCE % | -99.26 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| PS Ratio | 42.5 | |||||
| PB Ratio | 0.43 | |||||
| Price-to-Tangible-Book | 1.35 | |||||
| EV-to-EBIT | 0.28 | |||||
| EV-to-EBITDA | 0.29 | |||||
| EV-to-Revenue | -23.55 | |||||
| EV-to-FCF | 0.22 | |||||
| Price-to-Net-Current-Asset-Value | 1.35 | |||||
| Price-to-Net-Cash | 2.02 | |||||
| Earnings Yield (Greenblatt) % | 357.14 | |||||
| FCF Yield % | -236.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biodexa Pharmaceuticals Plc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.096 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 741.29 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -97.68 | ||
| 52-Week Range (€) | 0.01 - 2.24 | ||
| Shares Outstanding (Mil) | 94.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biodexa Pharmaceuticals Plc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biodexa Pharmaceuticals Plc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biodexa Pharmaceuticals Plc Frequently Asked Questions
What is Biodexa Pharmaceuticals Plc(FRA:5MP0)'s stock price today?
The current price of FRA:5MP0 is €0.04. The 52 week high of FRA:5MP0 is €2.24 and 52 week low is €0.01.
When is next earnings date of Biodexa Pharmaceuticals Plc(FRA:5MP0)?
The next earnings date of Biodexa Pharmaceuticals Plc(FRA:5MP0) is 2025-04-18 Est..
Does Biodexa Pharmaceuticals Plc(FRA:5MP0) pay dividends? If so, how much?
Biodexa Pharmaceuticals Plc(FRA:5MP0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers